Santhera bug\u00fcn, AGAMREE (vamorolone) i\u00e7in Biomedica ile olan m\u00fcnhas\u0131r da\u011f\u0131t\u0131m anla\u015fmas\u0131n\u0131 geni\u015fletti\u011fini ve ortakl\u0131\u011f\u0131n G\u00fcrcistan, Kazakistan, Belarus, Azerbaycan ve \u00d6zbekistan'\u0131 da kapsayacak \u015fekilde geni\u015fletildi\u011fini duyurdu. Bu ila\u00e7, iki ya\u015f ve \u00fczeri hastalarda Duchenne kas distrofisi (DMD) tedavisinde kullan\u0131lmaktad\u0131r.<\/p>\n\n\n\n
Biomedica, Ekim 2025'te AGAMREE\u00ae'nin distrib\u00fct\u00f6r\u00fc olarak atanm\u0131\u015ft\u0131. Geni\u015fletilmi\u015f anla\u015fma kapsam\u0131nda, Biomedica ek be\u015f pazarda da\u011f\u0131t\u0131mdan sorumlu olacakken, Santhera orijinal anla\u015fman\u0131n \u015fartlar\u0131na uygun olarak net sat\u0131\u015flardan belirli bir y\u00fczde almaya devam edecek. Bu ek \u00fclkelerde yakla\u015f\u0131k 2.000 hasta DMD ile ya\u015f\u0131yor ve tedavi se\u00e7enekleri tarihsel olarak b\u00fcy\u00fck \u00f6l\u00e7\u00fcde standart kortikosteroidlerle s\u0131n\u0131rl\u0131yd\u0131. Geni\u015fletilmi\u015f anla\u015fma, AGAMREE\u00ae'nin bu hastalara ula\u015f\u0131labilir hale gelmesinin yolunu a\u00e7\u0131yor. Daha Fazlas\u0131n\u0131 Okuyun: AGAMREE (Vamorolone) nedir?<\/a><\/p>\n\n\n\n <\/p>","protected":false},"excerpt":{"rendered":" Santhera today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the partnership to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, for the treatment of Duchenne muscular dystrophy (DMD) in patients two years of age and older. Biomedica was originally appointed as a distributor for AGAMREE\u00ae in October 2025. Under […]<\/p>\n","protected":false},"author":1,"featured_media":8252,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,846,845,433,843,844,41,43],"class_list":["post-8251","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-azerbaijan","tag-belarus","tag-biomedica","tag-georgia","tag-kazakhstan","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/8251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/comments?post=8251"}],"version-history":[{"count":1,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/8251\/revisions"}],"predecessor-version":[{"id":8253,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/posts\/8251\/revisions\/8253"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media\/8252"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/media?parent=8251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/categories?post=8251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/tr\/wp-json\/wp\/v2\/tags?post=8251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}